NCT00111384View on ClinicalTrials.gov

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

CompletedOBSERVATIONAL

Enrollment

313

Participants

Timeline

Start Date

July 27, 2005

Conditions

Neurofibromatosis Type 1Legius Syndrome

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00111384 - Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1) | Biotech Hunter | Biotech Hunter